| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/19/2007 | WO2007042239A1 Prolinamide derivatives as sodium channel modulators |
| 04/19/2007 | WO2007042178A1 Diacyl indazol derivatives as lipase and phospholipase inhibitors |
| 04/19/2007 | WO2007042146A1 Microangiopathy treatment and prevention |
| 04/19/2007 | WO2007042111A2 Use of estradiol valerate combined with dienogest for oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives |
| 04/19/2007 | WO2007042110A1 Method for manufacturing a monophasic pharmaceutical product for oral therapy of dysfunctional uterine bleeding |
| 04/19/2007 | WO2007042048A2 Method for preparing crystalline sodium risedronate |
| 04/19/2007 | WO2007042037A1 Tacrolimus combination products |
| 04/19/2007 | WO2007042035A2 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 04/19/2007 | WO2007042034A1 Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| 04/19/2007 | WO2007042010A2 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 04/19/2007 | WO2007041986A1 Antimitotic rhizoxin derivatives of burkholderia rhizoxina, method for producing said derivatives and use thereof |
| 04/19/2007 | WO2007041965A1 The application of trpc in screening anti-tumor medicaments and the pharmaceutical use of its inhibitor |
| 04/19/2007 | WO2007041951A1 Extraction method of abalone polysaccharide |
| 04/19/2007 | WO2007041950A1 Extraction method of patinopecten yessoensis polysaccharide |
| 04/19/2007 | WO2007041936A1 Alkyl alcohol piperazine derivative optical isomers and their salts and applications thereof |
| 04/19/2007 | WO2007041868A1 Method for detecting a biomarker of oxidative stress in a biological sample |
| 04/19/2007 | WO2007041863A1 Method for treating neuronal and non-neuronal pain |
| 04/19/2007 | WO2007041855A1 Scyllo-inositol derivatives and their use in the treatment of diseases characterised by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| 04/19/2007 | WO2007041842A1 An inflammatory mediator of cardiac adrenergic dysfunction |
| 04/19/2007 | WO2007041837A1 Cathepsin cysteine protease inhibitors |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007041832A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 04/19/2007 | WO2007041790A1 Salts of proton pump inhibitors and process for preparing same |
| 04/19/2007 | WO2007041775A1 Cysteine protease inhibitors incorporating azide groups |
| 04/19/2007 | WO2007041772A1 Preparation for the treatment of diarrhoea |
| 04/19/2007 | WO2007025994A3 Use of at least one 2-alkyl furan, as depigmenting or lightening active principle |
| 04/19/2007 | WO2007025632A3 Nitrooxy derivatives op glucocorticoids |
| 04/19/2007 | WO2007025055A3 Benztropine compounds and uses thereof as dopamine uptake inhibitors |
| 04/19/2007 | WO2007021189A3 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion |
| 04/19/2007 | WO2007020013A3 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 04/19/2007 | WO2007019440A3 Method for producing l-carnitine or acetyl-l- carnitine from germinating seeds |
| 04/19/2007 | WO2007019251A9 Sphingosine kinase inhibitors and methods of their use |
| 04/19/2007 | WO2007017895A3 Stabilized oral pharmaceutical compositions of cephalosporins |
| 04/19/2007 | WO2007017758A3 Novel cysteine protease inhibitors and their therapeutic applications |
| 04/19/2007 | WO2007017758A2 Novel cysteine protease inhibitors and their therapeutic applications |
| 04/19/2007 | WO2007017646A3 Anti-malarial composition comprising artesunate and lumefantrine |
| 04/19/2007 | WO2007017546A3 Method of obtaining tryptamine derivatives |
| 04/19/2007 | WO2007017544A3 Method of obtaining 3,3-diphenylpropylamines |
| 04/19/2007 | WO2007017127A3 Controlled realease dosage form of pirazole compounds to treat urinary incontinence |
| 04/19/2007 | WO2007016153A3 Tilmicosin formulation |
| 04/19/2007 | WO2007015923A3 Benzimidazoles useful as inhibitors of protein kinases |
| 04/19/2007 | WO2007015270A3 Novel controlled release compositions of selective serotonin reuptake inhibitors |
| 04/19/2007 | WO2007012870A3 Use of nefopam for the treatment of affective disorders |
| 04/19/2007 | WO2007012539A3 Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 04/19/2007 | WO2007011629A3 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 04/19/2007 | WO2007010369A3 Sustained release formulation of alprazolam |
| 04/19/2007 | WO2007009758A3 2r,4s) -4- (4-acetyl-3-hydroxy-1-piperazinyl) -n- { (1r) -1- [3, 5-bis (trifluoromethyl) phenyl] ethyl} -2- (4-fluoro-2-methylphenyl) -n-methyl-1-piperidine-carboxamide as tachykinin receptor antagonist |
| 04/19/2007 | WO2007009734A3 Combination preparation, particularly for treating prostate cancer |
| 04/19/2007 | WO2007009707A3 Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| 04/19/2007 | WO2007009704A3 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 04/19/2007 | WO2007009656A3 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 04/19/2007 | WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof |
| 04/19/2007 | WO2007009012A3 Compositions for oral administration of sustained release glutathione, methods for their production and uses thereof |
| 04/19/2007 | WO2007007152A3 Anti-madcam antibodies to treat metastatic cancers and chloroma |
| 04/19/2007 | WO2007006797A8 Use of 4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer |
| 04/19/2007 | WO2007006534A3 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 04/19/2007 | WO2007005887A3 Androgen receptor modulator compounds, compositions and uses thereof |
| 04/19/2007 | WO2007005541A8 Small molecule inhibitors against west nile virus replication |
| 04/19/2007 | WO2007004236A3 Improved drug or pharmaceutical compounds and a preparation thereof |
| 04/19/2007 | WO2007003422A9 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 04/19/2007 | WO2007003389A3 Substituted sulfolanyl pyrazoles and the use thereof |
| 04/19/2007 | WO2007002897A8 Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease |
| 04/19/2007 | WO2007002361A3 3-fluoro-piperidine t-type calcium channel antagonists |
| 04/19/2007 | WO2007001684A9 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 04/19/2007 | WO2007000339A8 Bicyclic derivatives as p38 kinase inhibitors |
| 04/19/2007 | WO2007000337A8 Bicyclic derivatives as p38 kinase inhibitors |
| 04/19/2007 | WO2007000325A3 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs |
| 04/19/2007 | WO2006138396A3 Methods for selective n-9 glycosylation of purines |
| 04/19/2007 | WO2006136419A3 Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
| 04/19/2007 | WO2006136408A3 Process for preparing pure amorphous rosuvastatin calcium |
| 04/19/2007 | WO2006134021A3 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 04/19/2007 | WO2006133837A3 A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide |
| 04/19/2007 | WO2006133199A3 Treatment with sigma receptor agonists post-stroke |
| 04/19/2007 | WO2006131398A3 Inhibitors of soluble adenylate cyclase |
| 04/19/2007 | WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors |
| 04/19/2007 | WO2006131322A3 Use op brivaracetam for the treatment of diseases characterized by progressive myoclonic epilepsy |
| 04/19/2007 | WO2006129859A3 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 04/19/2007 | WO2006128693A3 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system |
| 04/19/2007 | WO2006128159A3 North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses |
| 04/19/2007 | WO2006125813A3 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 04/19/2007 | WO2006125616A3 Pyrimidine-based cdk inhibitors for treating pain |
| 04/19/2007 | WO2006123354B1 Oral pharmaceutical composition |
| 04/19/2007 | WO2006123185A3 Sulphamides for treatment of cancer |
| 04/19/2007 | WO2006123184A3 Sulphonamido-substituted cyclohexyl sulphones for treatment of cancer |
| 04/19/2007 | WO2006120176A3 Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative |
| 04/19/2007 | WO2006119160A3 Polymer conjugate enhanced bioassays |
| 04/19/2007 | WO2006118973A3 Methods of using heterobyclic compounds for treatment of rectal cancer |
| 04/19/2007 | WO2006117139A3 Solid transdermal therapeutic system comprising uv absorber |
| 04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
| 04/19/2007 | WO2006115413A3 Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 04/19/2007 | WO2006112973A3 Treatment of schizophrenia using phosphodiesterase 5 inhibitors |
| 04/19/2007 | WO2006111296A3 Dosage forms and combined preparations of pyrimidine biosynthesis inhibitors for achieving additional effects upon the immune system |
| 04/19/2007 | WO2006110638A3 Inhibitors of akt activity |
| 04/19/2007 | WO2006109170A3 Combination therapy for treatment of cardiovascular diseases and related conditions |
| 04/19/2007 | WO2006105741B1 Topical pharmaceutical formulation containing nimesulide |
| 04/19/2007 | WO2006099385A3 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 04/19/2007 | WO2006086372A3 Compositions and methods for treatment of neurological symptoms associated with alcohol-withdrawal and for convulsive seizure |
| 04/19/2007 | WO2006084041A3 Nitroxides for use in treating or preventing diabetes |
| 04/19/2007 | WO2006083553A3 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase |
| 04/19/2007 | WO2006078942A3 Regulation of protein synthesis by inhibition of eif4e-eif4g interaction |